Inferno75
08-06

A lot of obstacles though making $

Novo Nordisk Second Quarter Sales Increase by 18%
Novo Nordisk, the maker of Wegovy, reported an 18% increase in sales in the second quarter. This growth comes after a major profit warning and the announcement of a new CEO, which led to a significant decrease in the company's stock value.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment